Natera

Incyte

United Therapeutics

Gilead Sciences

Insmed

Neurocrine Biosciences

Vertex Pharmaceuticals

Alnylam Pharmaceuticals

AbbVie

Sarepta Therapeutics

SPDR S&P Biotech ETF

XBI tracks an equal-weighted index of US biotechnology stocks.

iShares Nasdaq Biotechnology ETF

Biotechnology sector-related exchange traded funds are on a four-day streak and gaining momentum, breaking above their short-term trend lines. On Friday, SPDR S&P Biotech ETF (NYSEArca: XBI) rose 2.9% while the iShares Nasdaq Biotechnology ETF (IBB), the largest biotech-related ETF by assets, gained 1.8%.

Investors Should Take a Look at the Beaten Down Biotech ETFs

iShares North American Tech-Software ETF

iShares U.S. Home Construction ETF

iShares Russell Mid-Cap Growth ETF

WisdomTree Cloud Computing Fund

U.S. stocks are currently on sale compelling investors to buy on the dip.

5 Top-Ranked ETFs on Sale

Small-cap biotechnology companies are on track for the worst 12 months in more than 15 years when compared with their large-cap biotech peers, according to Raymond James analysts. Small-cap biotechs outperformed large-cap biotechs in only one month-August-out of the past 12 months.

Raymond James: Small-cap biotechs on track for 'worst 12-month run' in decades

Invesco QQQ

SPDR S&P 500 ETF Trust

The bears have two major tailwinds and the Fed is one. Here are 3 ETF stocks to buy into a potential relief rally after the event blows over.

3 Market ETF Stocks to Buy This Week on Fed Jitters

The outlook for the pharmaceutical and biotech industry is good thanks to resilience versus crises and large macro tailwinds.

Is XBI ETF A Buy Or Sell In 2022 For ETF Investors?

Wall Street seems to have a grudge against the entire sector at the moment.

This Trend Is the Biggest Risk to Biotech Investors Right Now

VanEck Vectors Biotech ETF

The macroeconomic backdrop of Fed interest rate hikes is rapidly deflating overvalued technology companies and "crypto-collectibles." We expect the technology sector to underperform value and biotech.

XBI And IBB: Sell Technology And Buy Biotech, The Only Undervalued Non-Cyclical Growth Sector

Alibaba

Opinion Follows Trend. Sentiment is at an extreme low on Biotech and Chinese Tech.

Biotech And China Tech, Left For Dead. Time To Step In - XBI, BABA?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

How Are Biotech ETFs Reacting to These Q4 Earnings Releases?

AdvisorShares Pure US Cannabis ETF

They've taken a beating, but the industries they track are still growing.

3 Growth ETFs to Consider Buying During This Correction

The XBI Index has had an accumulated collapse in the last year of approximately 50%. It is a historic fall because it had never suffered such a collapse before.

XBI: The Worst Is Over

XBI: Market Runs From Risk In Times Of Uncertainty

Aurinia Pharmaceuticals

Bausch Health Companies Inc

Clovis Oncology

Myovant Sciences

Cassava Sciences Inc

Biotechs have been one of the worst performers for 2021 as the pandemic has wrought havoc in the sector. 2022 will likely entail a rotation out of high valuation sectors like technology into more depressed sectors like healthcare.

6 Top Biotech Ideas For 2022

ARK Innovation ETF

iShares MSCI EAFE Growth ETF

Amplify Online Retail ETF

Global X Lithium & Battery Tech ETF

Vanguard Small-Cap Growth

Vanguard Growth ETF

Vanguard FTSE Emerging Markets ETF

These growth ETFs offer exposure to higher-risk, higher-reward stocks while lessening the risk of a single stock torpedoing your returns.

9 Great Growth ETFs for 2022

2021 has been a real tough year for biotech investors, and the start of 2022 doesn't bring a sign of relief yet. Nonetheless, if history is of any guide, large trading volumes over the past month are an indication that better days might be waiting ahead.

Biotech Investing: Large Trading Volumes Suggest Better Days Are Ahead

Biogen

Direxion Daily S&P Biotech Bull 3X Shares

The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.

3 Biotech Stocks to Buy That Are Under Severe Pressure

ETF Battles: IBB Vs XBI

Despite economic uncertainty, big biopharma companies have tons of cash to spend on deals.

Will M&A Perk Up Biotech After a Miserable 2021?

APA Corporation

Asana

Coterra Energy

Disney

DocuSign

Devon Energy

EOG Resources

Ford Motor Company

Diamondback Energy

Kosmos Energy

monday.com

ServiceNow

VanEck Vectors Oil Services ETF

Plains GP Hlds

Paysafe

PayPal

Tellurian

Tesla

Twilio

Upstart Holdings

Vector Group

Xerox

SentinelOne

The Market is having crazy volatility, Does that mean retreat? No. What about inflation, What about soaring interest rates? Bad news? That isn't the message of the market.

I Spy With My Big Eagle Eye Some Stocks I May Want To Buy

Adagio Therapeutics

Editas Medicine

All three of these biotech stocks lost around half their value over the past few months.

3 Beaten-Down Biotech Stocks -- Are They Bargains Now?

Invesco S&P 500 Enhanced Value ETF

Vanguard Financials ETF

Invesco S&P MidCap Value with Momentum ETF

SPDR S&P Retail ETF

With the easing of Omicron fears, Wall Street jumped to start a new week after a broad market sell-off in the past couple of weeks.

5 Top-Ranked ETFs to Buy At Bargain Prices

Adaptimmune Therapeutics

Affimed

Axsome Therapeutics

BridgeBio Pharma Inc

BioCryst Pharmaceuticals

Beam Therapeutics

Amicus Therapeutics

These eight stocks could rebound nicely over the next year and beyond.

8 Beaten-Down Pharmaceutical Stocks That Could Skyrocket In 2022

Although the Healthcare sector is having a positive year in absolute terms, that isn't the case in relative terms.

IBB And XBI: 4 Reasons To Buy Biotech Stocks Ahead Of 2022

I had rated the SPDR S&P Biotech ETF as bullish in July 2020. The ETF's price spiked by 51% thereafter, and later, regressed to its mean. Historical data reveal that the ETF delivered solid price gains in the long run, but current market conditions suggest that it faces many headwinds in the near term.

SPDR S&P Biotech ETF: Of Headwinds And Tailwinds

You may feel strange that we hold the SPDR S&P Biotech ETF (XBI) for our retirement. It pays negligible dividends and the biotech sector is the opposite of the “safe” sectors that retirees go for.

XBI: 3 Reasons Why We Hold It In Our Retirement Portfolio

News for SPDR S&P Biotech ETF ETF (XBI)